Spanish start-up biotechnology company, OrphaMed (Valladolid), has licensed IDBS’s ActivityBase Suite and E-WorkBook to manage its complete drug discovery workflow.
Focusing initially on research for new drug indications for haematological cancers, OrphaMed sought a comprehensive data management solution that could easily store all of its research data. ActivityBase XE and E-WorkBook, IDBS’ versatile electronic laboratory notebook (ELN), integrate seamlessly to deliver the high level of flexibility demanded by OrphaMed’s scientists.
Juan Ballesteros, chief scientific officer of OrphaMed, said: ‘E-WorkBook will allow us to store all our research data and notes and comply with regulatory standards for clinical data in one secure environment, which will in turn lead to enhanced decision making.’
